Sobi to advance Gamifant in interferon-gamma-driven sepsis based on EMBRACE topline data: Stockholm Friday, January 9, 2026, 11:00 Hrs [IST] Sobi, a global biopharma company, anno ...
ACROBiosystems — the leading producer of recombinant proteins and other vital reagents to encourage the development of target therapeutics, diagnostics, and vaccines — has established an antibody ...
The rights offering for The India Fund, Inc. (IFN) expired on May 14, 2024. From the press release: The India Fund, Inc. [NYSE: IFN] (the "Fund"), a closed-end fund, announced today the successful ...
Sobi vidareutvecklar Gamifant® (emapalumab) vid gammainterferon-driven sepsis (IDS) baserat på topline-data från EMBRACE (2) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback